Inventor · disambiguated record
Lars Abrahmsen
Also filed as: ABRAHMSEN LARS · ABRAHMSEN LARS B · ABRAHMSÉN LARS B · Abrahmsén Lars
30 granted patents·12 pending applications·668 citations·filing 1990–2023
97Inventor score
Top patents by PatentIndex Score
42 records- 0193US7226595B2Modified Chimeric superantigens and their useACTIVE BIOTECH AB·Filed 2002·Granted Jun 5, 2007·69 cites·9 claims
- 0290US8937153B2Compositions, methods and usesAbrahmsén Lars·Filed 2008·Granted Jan 20, 2015·22 cites·49 claims
- 0389US5876968ADimer of molecular variant of apolipoprotein and processes for the production thereofPHARMACIA & UPJOHN AB·Filed 1992·Granted Mar 2, 1999·85 cites·7 claims
- 0489US5143844AConstruction of an igg binding protein to facilitate downstream processing using protein engineeringKABIGEN AB·Filed 1990·Granted Sep 1, 1992·96 cites·30 claims
- 0588US10159760B2HER2 bindersGEN ELECTRIC·Filed 2016·Granted Dec 25, 2018·4 cites·6 claims
- 0688US8501909B2Polypeptides having affinity for HER2ABRAHMSEN LARS·Filed 2008·Granted Aug 6, 2013·19 cites·29 claims
- 0788US6514498B1Modified/chimeric superantigens and their usePHARMACIA AB·Filed 1996·Granted Feb 4, 2003·99 cites·12 claims
- 0886US9469670B2Polypeptide libraries with a predetermined scaffoldAbrahmsén Lars·Filed 2008·Granted Oct 18, 2016·8 cites·9 claims
- 0984US9211344B2PolypeptidesEKBLAD CAROLINE·Filed 2011·Granted Dec 15, 2015·11 cites·45 claims
- 1084US6617134B1Dimer of molecular variant of apolipoprotein and processes for the production thereofESPERION THERAPEUTICS INC·Filed 1999·Granted Sep 9, 2003·56 cites·18 claims
- 1182US8883120B2Polypeptides having affinity for HER2AFFIBODY AB·Filed 2013·Granted Nov 11, 2014·6 cites·22 claims
- 1281US9175067B2Immunoglobulin G Fc region binding polypeptideABRAHMSEN LARS·Filed 2011·Granted Nov 3, 2015·4 cites·26 claims
- 1381US6962694B1Cytolysis of target cells by superantigen conjugates inducing T-cell activationACTIVE BIOTECH AG·Filed 1998·Granted Nov 8, 2005·60 cites·12 claims
- 1480US10894097B2HER2 bindersGEN ELECTRIC·Filed 2018·Granted Jan 19, 2021·1 cites·10 claims
- 1580US2024139352A1Her2 bindersGEN ELECTRIC·Filed 2023·Application pending·0 cites
- 1679US5403737ASerine protease variants having peptide ligase activityGENENTECH INC·Filed 1991·Granted Apr 4, 1995·51 cites·21 claims
- 1776US5629173AMethods of use of serine protease variants having peptide ligase activityGENENTECH INC·Filed 1995·Granted May 13, 1997·34 cites·27 claims
- 1874US11633507B2HER2 bindersGEN ELECTRIC·Filed 2020·Granted Apr 25, 2023·0 cites·8 claims
- 1974US10556933B2Polypeptide libraries with a predetermined scaffoldAFFIBODY AB·Filed 2016·Granted Feb 11, 2020·1 cites·20 claims
- 2074US10323066B2Neonatal Fc receptor binding dimer and methods of useAFFIBODY AB·Filed 2015·Granted Jun 18, 2019·2 cites·23 claims
- 2174US10118949B2Compositions, methods and usesAFFIBODY AB·Filed 2014·Granted Nov 6, 2018·1 cites·20 claims
- 2273US9238810B2PolypeptideJARSTAD ANDERS ERIK·Filed 2008·Granted Jan 19, 2016·4 cites·36 claims
- 2371US9975943B2PolypeptidesAFFIBODY AB·Filed 2014·Granted May 22, 2018·2 cites·46 claims
- 2466US9957330B2PolypeptidesAFFIBODY AB·Filed 2013·Granted May 1, 2018·1 cites·19 claims
- 2566US7226601B1Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugateACTIVE BIOTECH AB·Filed 1995·Granted Jun 5, 2007·13 cites·2 claims
- 2661US2005226885A1Cytolysis of target cells by superantigen conjugates inducing T-cell activationACTIVE BIOTECH AB·Filed 2004·Application pending·0 cites
- 2760US2020199197A1PolypeptidesAFFIBODY AB·Filed 2020·Application pending·0 cites
- 2858US5736512ASerine protease variants having peptide ligase activityGENENTECH INC·Filed 1995·Granted Apr 7, 1998·12 cites·12 claims
- 2958US2019375799A1PolypeptidesAFFIBODY AB·Filed 2019·Application pending·0 cites
- 3054US2022339141A1Combination treatment with a p53 reactivator and an inhibitor of an antiapoptotic bcl-2 family proteinAPREA THERAPEUTICS AB·Filed 2020·Application pending·0 cites
- 3153US10562955B2PolypeptidesAFFIBODY AB·Filed 2017·Granted Feb 18, 2020·0 cites·47 claims
- 3252US10329331B2PolypeptidesAFFIBODY AB·Filed 2015·Granted Jun 25, 2019·0 cites·60 claims
- 3352US2012165650A1Her2 bindersSYUD FAISAL AHMED·Filed 2010·Application pending·0 cites
- 3452US2006062795A1Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugateABRAHMSEN LARS·Filed 2005·Application pending·0 cites
- 3552US2005260215A1Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugateABRAHMSEN LARS·Filed 2005·Application pending·0 cites
- 3649US2019284241A1Neonatal Fc Receptor Binding Dimer and Methods of UseAFFIBODY AB·Filed 2019·Application pending·0 cites
- 3748US6723553B2Promoter sequencesBIOVITRUM AB·Filed 2001·Granted Apr 20, 2004·0 cites·12 claims
- 3845US2018230235A1PolypeptidesAFFIBODY AB·Filed 2018·Application pending·0 cites
- 3944US2002160482A1Methods for protein purificationFiled 2002·Application pending·0 cites
- 4043US5763256ASerine protease variants having peptide ligase activityGENENTECH INC·Filed 1994·Granted Jun 9, 1998·5 cites·32 claims
- 4141US2005186659A1Methods for protein purificationFiled 2005·Application pending·0 cites
- 4232US5156959AMethod to export gene products to the growth medium of gram negative bacteriaKABIGEN AB·Filed 1990·Granted Oct 20, 1992·2 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Lars Abrahmsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →